Withings, the pioneer in futuristic health tech devices, has unveiled its latest innovation at CES 2024 – the Withings BeamO. Priced at $250, the BeamO is a groundbreaking multiscope designed to empower individuals and families to monitor their health comprehensively from the comfort of their homes.
This compact device is no ordinary thermometer; it’s a multifunctional health powerhouse. The BeamO can measure your temperature, take electrocardiograms (EKG), read blood oxygen levels, and even serve as a stethoscope to monitor heart and lung health. It’s like having a mini-clinic in your hands.
The BeamO incorporates advanced technology, including photoplethysmography (PPG) sensors, electrodes for EKG readings, and a digital stethoscope featuring a piezoelectric disc. This disc captures acoustic noise from your chest or back and converts it into an electric signal, providing an accurate assessment of your heart and lung health.
Moreover, Withings has ensured seamless integration with telehealth sessions, allowing users to stream audio directly to their healthcare providers. The device also comes with a USB-C to headphone jack adaptor for personal listening.
While many of these health measurements are already available individually, the BeamO’s innovation lies in consolidating them into a single, user-friendly device suitable for the entire family. However, it’s important to note that features like EKG and AFib detection will require FDA clearance.
Withings plans to release the BeamO in June of this year, but as history has shown, FDA clearance timelines can be unpredictable. Nevertheless, Withings’ commitment to building an extensive at-home health platform is evident, and the Withings BeamO represents the latest addition to this growing ecosystem, offering convenience, accessibility, and peace of mind for health-conscious individuals and families alike.
In other news from Withings, check out the Withings ScanWatch Nova.